Lucerum, Inc. provides EEG-focused, cloud-scale neuroanalytics platforms and CRO services with end-to-end data collection and analytics for pharmaceutical and clinical research.
Our LucerumKey platform is geared toward scalable research and eliminates software silos in preclinical and clinical trials by unifying physiologic signal analytics on a cross-species cloud platform. It automates pharmaco-EEG, multimodal neuroimaging, and brain network–level analytics, creating an integrated framework for translational drug development with bioinformatics integration.
Our LucerumCarto platform supports personalized brain assessments, diagnostics, and predictive outcomes with rapid EEG tomography, network connectomics, qEEG-guided TMS, and neuromodulation support. Both platforms are expanding with ML-driven modules for patient cohort discovery, trend analysis, biomarker identification, and individualized neuromodulation strategies.